Emerging within the UK, retatrutide, a new compound , is sparking considerable buzz within the scientific community regarding its ability for body regulation. This dual GIP and GLP-1 target agonist looks to deliver a significant benefit over current therapies, showing encouraging results in preliminary clinical assessments. Researchers believe i… Read More